PT Kalbe Farma Tbk. (PTKFF)

USD 0.1

(0.0%)

Inventory Summary of PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk.'s latest annual inventory in 2023 was 451.27 Million USD , down -1.23% from previous year.
PT Kalbe Farma Tbk.'s latest quarterly inventory in 2024 Q2 was 399.01 Million USD , down -5.28% from previous quarter.
PT Kalbe Farma Tbk. reported annual inventory of 456.88 Million USD in 2022, up 26.43% from previous year.
PT Kalbe Farma Tbk. reported annual inventory of 361.38 Million USD in 2021, up 35.58% from previous year.
PT Kalbe Farma Tbk. reported quarterly inventory of 421.25 Million USD for 2024 Q1, down -6.65% from previous quarter.
PT Kalbe Farma Tbk. reported quarterly inventory of 399.01 Million USD for 2024 Q2, down -5.28% from previous quarter.

Annual Inventory Chart of PT Kalbe Farma Tbk. (2023 - 2015)

Historical Annual Inventory of PT Kalbe Farma Tbk. (2023 - 2015)

Year	Inventory	Inventory Growth
2023	451.27 Million USD	-1.23%
2022	456.88 Million USD	26.43%
2021	361.38 Million USD	35.58%
2020	266.55 Million USD	-4.75%
2019	279.85 Million USD	11.7%
2018	250.55 Million USD	-8.75%
2017	274.59 Million USD	7.24%
2016	256.04 Million USD	10.56%
2015	231.58 Million USD	0.0%

Year	Inventory	Inventory Growth
2024 Q3	440.56 Million USD	1630480.31%
2024 Q1	421.25 Million USD	-6.65%
2024 Q2	399.01 Million USD	-5.28%
2023 Q3	477.36 Million USD	-5.36%
2023 FY	451.27 Million USD	-1.23%
2023 Q2	504.37 Million USD	-1.55%
2023 Q1	512.32 Million USD	12.13%
2023 Q4	451.27 Million USD	-5.46%
2022 Q4	456.88 Million USD	3.92%
2022 FY	456.88 Million USD	26.43%
2022 Q3	439.64 Million USD	6.52%
2022 Q1	394.93 Million USD	9.28%
2022 Q2	412.74 Million USD	4.51%
2021 Q1	293.58 Million USD	0.0%
2021 FY	361.38 Million USD	35.58%
2021 Q3	313.13 Million USD	2.24%
2021 Q4	361.38 Million USD	15.41%
2021 Q2	306.29 Million USD	4.33%
2020 FY	266.55 Million USD	-4.75%
2019 FY	279.85 Million USD	11.7%
2018 FY	250.55 Million USD	-8.75%
2017 FY	274.59 Million USD	7.24%
2016 FY	256.04 Million USD	10.56%
2015 FY	231.58 Million USD	0.0%

Peer Inventory Comparison of PT Kalbe Farma Tbk.

Name	Inventory	Inventory Difference
AstraZeneca PLC	5.41 Billion USD	91.668%
Bristol-Myers Squibb Company PFD CONV 2	2.66 Billion USD	83.047%
CSPC Pharmaceutical Group Limited	442.43 Million USD	-2.0%
Clarus Therapeutics Holdings, Inc.	14.21 Million USD	-3074.897%
Novartis AG	5.91 Billion USD	92.368%